Market Vectors® Pharmaceutical ETF
(NYSE ARCA: PPH)
AdChoices
62.28
+0.74
+1.20%
:

Open

61.84

Net Assets

363.16M

Day's Range

61.62-62.32

52 week range

49.62-64.54

Category

Health

Vol (3-Month Avg.)

97.96k

Yield

1.63%

Morningstar Risk

-

AdChoices
Performance
Returns %
Key statistics
  • Composition
  • Performance
  • Top Holdings
  • Key Statistics
Composition
Top Equity Sector Holding
Equity Investment Style
The two dimensions of the Fund Style box measure the average size of companies that have been in the ETF, from the top to bottom, and the average valuation characteristics of the ETF's past stock holdings, from left to right.

PERFORMANCE

  • Total Return %

  • 1 Day

  • 1 Week

  • 1 Month

  • 3 Months

  • 1 Year

  • 3 Years

  • 5 Years

    • PPH

    • 1.19

    • 5.27

    • -2.64

    • 0.84

    • 26.67

    • -

    • -

    • Category(Health)

    • 1.16

    • 6.08

    • 0.85

    • 6.37

    • 27.09

    • 28.30

    • 23.07

    • Rank in Category

    • 59

    • 77

    • 95

    • 95

    • 50

    • -

    • -

    MORNINGSTAR RATING

    • Years

    • Return

    • Risk

    • Rating

      • 3 Years

      • -

      • -

      • -

      • 5 Years

      • -

      • -

      • -

      • 10 Years

      • -

      • -

      • -

      • Overall

      • -

      • -

      • -

      TOP HOLDINGS

      • Name

      • % Portfolio Weight

      • Shares Held

      • Change

        • Johnson & Johnson

        • 10.99

        • 397,206

        • 0

        • Novartis AG ADR

        • 9.79

        • 406,829

        • 0

        • Pfizer Inc

        • 7.27

        • 943,203

        • 0

        • Merck & Co Inc

        • 5.71

        • 374,311

        • 0

        • Sanofi ADR

        • 5.50

        • 381,149

        • 0

        • Novo Nordisk A/S ADR

        • 5.09

        • 412,793

        • 0

        • GlaxoSmithKline PLC ADR

        • 4.91

        • 401,183

        • 0

        • AbbVie Inc

        • 4.79

        • 298,495

        • 0

        • Bristol-Myers Squibb Company

        • 4.73

        • 334,201

        • 0

        • Actavis PLC

        • 4.62

        • 72,229

        • 0

        CATEGORY

        • Name

        • PPH

        • Category

          • Avg. Market Cap USD (M)

          • 99,100.23

          • 27,214.31

          • Expense Ratio

          • 0.35%

          • 0.44%

          • Net Assets

          • 363.16M

          • 1.06B

          • Price/Prospective Earnings

          • 21.31

          • 21.83

          • Price/Book

          • 3.61

          • 4.82

          • Price/Sales

          • 2.92

          • 3.25

          • Price/Cash Flow

          • 16.38

          • 19.29

          • Dividend Yield

          • 2.13%

          • 2.13

          Profile

          Name of Issuer

          Market Vectors

          Expenses

          0.35%

          The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors® US Listed Pharmaceutical 25 Index (the "Pharmaceutical Index"). The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

          Inception

          12/20/2011